HOOKIPA Pharma Inc.
CEO
CEO
HOOKIPA Pharma Inc.
Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
Joern Aldag is recorded as CEO at HOOKIPA Pharma Inc.. HOOKIPA Pharma Inc. reported in an 8-K filed July 26, 2024 that Joern Aldag resigned as director, effective July 23, 2024. The proxy statement of HOOKIPA Pharma Inc. reports total compensation of $1,130,427 for Joern Aldag in fiscal 2023, including a base salary of $567,451. Disclosed compensation is on record for 5 fiscal years. Joern Aldag has spoken on 3 earnings calls across 1 company, most recently for HOOKIPA Pharma Inc. on March 15, 2023.
“Mr. Aldag also resigned from his position as a director of the Company on July 23, 2024 following his separation as Chief Executive Officer as stipulated by his employment agreement with Hookipa Biotech GmbH ("Hookipa Biotech"), the Company's wholly owned subsidiary, pursuant to which Mr. Aldag provided services to the Company.”
Summary generated from SEC filings and earnings-call records held by Equibles.
Recorded current and former roles; source labels appear when available.
HOOKIPA Pharma Inc.
CEO
Proxy statement
Start not stated–present
HOOKIPA Pharma Inc.
Board Member
Proxy statement
Start not stated–2024-07-23
Recorded roles and call appearances connecting this person to public companies.
HOOKIPA Pharma Inc.
CEO
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2023 | HOOKIPA Pharma Inc. | Chief Executive Officer | $567,451 | $1,130,427 |
| 2022 | HOOKIPA Pharma Inc. | Chief Executive Officer | $389,601 | $1,250,408 |
| 2021 | HOOKIPA Pharma Inc. | Chief Executive Officer | $572,334 | $2,605,450 |
| 2019 | HOOKIPA Pharma Inc. | Chief Executive Officer | $469,205 | $6,367,981 |
| 2018 | HOOKIPA Pharma Inc. | Chief Executive Officer | $361,600 | $547,592 |
Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.
HOOKIPA Pharma Inc. Q4 FY2022 Earnings Call
HOOKIPA Pharma Inc.
HOOKIPA Pharma Inc. Q4 FY2021 Earnings Call
HOOKIPA Pharma Inc.
HOOKIPA Pharma Inc. Q4 FY2020 Earnings Call
HOOKIPA Pharma Inc.